Merck Kgaa (MKGAF) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck Kgaa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.071 -- 00:00:05.575 Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference call 00:00:05.575 -- 00:00:09.018 on Q2 2026. 00:00:09.018 -- 00:00:14.161 As a reminder, all participants will be in a listen-only mode. 00:00:14.161 -- 00:00:19.245 I am now handing over to Florian Schraeder, Head of Investor Relations, who will lead 00:00:19.245 -- 00:00:23.647 you through this conference. Please go ahead, sir. 00:00:24.013 -- 00:00:29.376 Thank you very much Heidi. Good afternoon, good morning everyone and welcome to our Q2 00:00:29.376 -- 00:00:33.118 26 results call. Thank you for joining us today. 00:00:33.118 -- 00:00:37.760 My name is Florian Schraeder and I'm the Head of Investor Relations at Merck. 00:00:37.760 -- 00:00:42.943 In our Q2 call today, Kai Beckmann, Group CEO, will begin with sharing an update 00:00:42.943 -- 00:00:47.285 on first steps since we announced our new strategic direction in May. 00:00:47.285 -- 00:00:51.907 Kai will then provide a brief overview of our business performance and key developments 00:00:51.907 -- 00:00:56.114 in the second quarter as part of his executive summary. 00:00:56.114 -- 00:01:01.456 Helene von Roeder, Group CFO, will guide you through the detailed financial overview. 00:01:01.456 -- 00:01:06.037 Before we move into the Q&A session, where we will be joined by Jean Charles Wirth, CEO 00:01:06.037 -- 00:01:12.100 of LifeScience, Danny Bar-Zohar, CEO of Healthcare, and Benjamin Hein, CEO of Electronics, 00:01:12.100 -- 00:01:15.501 Kai will share our updated outlook and guidance with you. 00:01:15.501 -- 00:01:20.186 With that, I'm pleased to hand it over to Kai to kick us off. 00:01:20.186 -- 00:01:25.528 Thank you, Florian, and good afternoon, good morning, and thanks to you all f...